u/kavya_kravchenko

This is the "correlation is mechanism" thing again. You changed three variables at once.

503B compounding is different from 503A, different rules, different legality

Not to be pedantic but compounding and API source are being used interchangeably and they are not interchangeable in real life.

Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

telehealth prescriber models exist, pricing differs by state

No.

Disagree on that part. 96.8% and 96.2% on the same vial is normal.

private 0.5mg is MHRA in Spain this month

Small correction: the trial was 9 weeks, not 38. Does not change your point but people will quote it.

pharmacy stock is tier 3, check before traveling

Where does the appetite data actually come from?

the Scottish pathway is different from the English one

Respectfully this is a sample of one presented as a finding.

severe abdominal pain is an urgent-care question, not a forum question

telehealth costs 503B plus compounding markup, total varies

Small correction: the trial was 9 weeks, not 19. Does not change your point but people will quote it.

You have restated the marketing copy. What is the actual substance here.

severe abdominal pain is an urgent-care question, not a forum question

Disagree on that part. 99.2% and 99.3% on the same vial is normal.

Are you on a pen or research vial? The formulation changes the profile.